A comprehensive invasive assessment of coronary physiology in adult patients with cardiogenic shock

Alfred Health0 个研究点目标入组 30 人开始时间: 2021年9月17日最近更新: 2021年9月27日

适应症

试验速览

暂无简介。

•1. Ages of 18 and above.
•2. Coronary angiography being undertaken as part of routine patient care as determined by the treating team.
•3. SCAI Shock stage C or less
•4.Onset of symptoms <24 hours prior.
•5.Measurements to be performed at time of coronary angiography

•Pregnant and breastfeeding women, due to the radiation exposure inherent to this study
•Non-cardiac cause of shock (e.g. pulmonary embolism, pneumothorax, cardiac tamponade, etc.)
•Active bleeding
•Prior coronary artery bypass grafting
•Mechanical complication of surgery
•Known left ventricular thrombus
•Mechanical aortic valve
•Patients with contraindications to adenosine including: asthma/bronchospasm, greater than first degree heart block or sick sinus syndrome without a pacemaker, symptomatic aortic stenosis or hypertrophic cardiomyopathy, cerebral ischaemia or current dipyridamole medication use.
•Considered prohibitively hemodynamically unstable (e.g. Noradrenaline dose>50mcg/min)
•Prolonged cardiac arrest (in or out-of-hospital) > 20 minutes prior to return of spontaneous circulation
•Death is considered imminent

发起方